However, under conditions where p62 facilitates the selective autophagic degradation of oncogenic proteins or damaged mitochondria, it may exert tumor-suppressive effects, as reported in hematological malignancies and early-stage hepatocellular carcinoma [8, 23, 66]. This evidence concerns the gene SQSTM1 and hepatocellular carcinoma.